Clinical trial · Interventional
Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors
A Pilot Study to Examine Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Investigators are conducting this study to find out more about what heart health means to participants and how healthcare providers can best help to manage heart health. Participants will be asked to view an electronic tool designed to promote heart health awareness and help to manage heart health outside of the clinic. This study will provide important information to help investigators develop future programs that improve cancer patient's heart health after they complete their treatment.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
| Survivorship | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Interview Regarding Heart Health | Other | — | UNRESOLVED |
| PREVENT Cardiovascular Health Assessment Tool | Other | — | UNRESOLVED |
| Survey | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- PREVENT - Cardiovascular Health Assessment Tool
- description
- An adapted version of the PREVENT tool for endometrial cancer survivors will be used collect data during routine follow-up care for endometrial cancer that will yield a cardiovascular health score based on the Simple 7 risk factors (current smoking habits, body mass index, physical activity, diet, cholesterol, blood pressure and fasting plasma glucose).
- interventionNames
- Other: PREVENT Cardiovascular Health Assessment Tool
- Other: Survey
- Other: Interview Regarding Heart Health
Primary outcomes (1)
- measure
- Number of Participants to Complete Intervention - Feasibility
- timeFrame
- 6 months
- description
- Feasibility will be defined from the number of participants who complete the web-based assessment using exact 95% binomial confidence intervals.
Secondary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Scheduled for a routine surveillance visit for pathologically confirmed stages I-IV endometrial cancer * Greater than or equal to 3 months post-potentially curative cancer treatment * Patients must be at least 18 years of age * Have a working email address * Comfortable reading medical information in English, as per self-report Exclusion Criteria: * Currently receiving treatment (e.g. radiation, chemotherapy, immunological treatments for endometrial cancer) * Have a history of endometrial cancer recurrence * Enrolled in hospice care or documentation of life expectancy \< 6 months
References
Publications (0)
Data not yet available